Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03910075 · ClinicalTrials.gov registry record · Phase 3
Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)
A Phase 3 study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- Phase 3
- Development phase
- 216
- Enrollment target
NCT03910075 is a Phase 3 study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 216 participants.
The verdict
NCT03910075, a Phase 3 study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 216 participants
- Enrollment target
Study Summary
This is a Phase III clinical trial to compare the efficacy of two dosages of a new infant rehabilitation protocol - I-ACQUIRE - to usual and customary forms of infant rehabilitation in infants who experienced Perinatal Arterial Stroke (PAS).
Interventions
- BEHAVIORAL I-ACQUIRE - High Dosage
- BEHAVIORAL I-ACQUIRE - Moderate Dosage
- BEHAVIORAL Usual & Customary Treatment (U&CT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2025-07-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03910075
The ClinicalTrials.gov registry entry for NCT03910075 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which I-ACQUIRE - High Dosage is the first listed.
NCT03910075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03910075 about?
NCT03910075 is a clinical study titled "Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)". This is a Phase III clinical trial to compare the efficacy of two dosages of a new infant rehabilitation protocol - I-ACQUIRE - to usual and customary forms of infant rehabilitation in infants who experienced Perinatal Arterial Stroke (PAS).
What is the current status of trial NCT03910075?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 216 participants. The study started on 2019-10-10. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT03910075?
The interventions under investigation include: I-ACQUIRE - High Dosage (BEHAVIORAL), I-ACQUIRE - Moderate Dosage (BEHAVIORAL), Usual & Customary Treatment (U&CT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03910075?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.